🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsHas anyone dealt with expected approval timeline for retatrutide? Page 2

Has anyone dealt with expected approval timeline for retatrutide?

PurityPaulOR Wed, Jun 26, 2024 at 4:02 AM 6 replies 1,843 viewsPage 2 of 2
MikeNYC_runner
Member
378
1,678
Jul 2024
New York, NY
Jun 26, 2024 at 8:23 AM#6

I've seen people on Reddit saying they've already used retatrutide from research chemical companies. Is that the same drug? Should I try to get it now instead of waiting?

Last edited: Jun 26, 2024 at 10:23 AM
32 2PedsEndoPhilly, SleepDoc_PDX, RegAffairsDC and 29 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 26, 2024 at 10:06 AM#7

I need to address this directly. Research chemical / peptide vendor "retatrutide" is NOT the same as pharmaceutical-grade retatrutide from Eli Lilly's clinical trials. Key differences:

  • Purity: Pharmaceutical grade is ≥99% pure with rigorous quality control. Research peptides vary wildly in purity and may contain degradation products or contaminants.
  • Identity: Without independent analytical testing, you have no guarantee the product is actually retatrutide (or that the dose is accurate).
  • Medical oversight: Clinical trial participants have regular monitoring, bloodwork, and medical supervision. Self-administering a research chemical does not.
  • Legal status: Retatrutide is an investigational drug. Selling it for human consumption outside of a clinical trial is illegal in most jurisdictions.

We do not allow discussion of sourcing or using research chemicals on this forum. This is for your safety. Please be patient and wait for the approved product under medical supervision.

31 1SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 28 others
Reply Quote Save Share Report
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Jun 26, 2024 at 11:49 AM#8

I want to add a broader perspective here. The timeline frustration is understandable, but it's worth remembering how fast this field is actually moving. Consider:

  • 2014: Saxenda (liraglutide 3.0mg) approved — ~8% weight loss, daily injection
  • 2021: Wegovy (semaglutide 2.4mg) approved — ~15% weight loss, weekly injection
  • 2023: Zepbound (tirzepatide) approved — ~22% weight loss, weekly injection
  • 2027?: Retatrutide — ~24% weight loss, weekly injection

In 13 years, we went from 8% to 24% weight loss. That's a tripling of efficacy in barely over a decade. In pharmaceutical terms, that's warp speed. The drug you're on right now (tirzepatide) was inconceivable 10 years ago.

Yes, waiting is hard. But you're not waiting with nothing — you're on an already-excellent medication. When retatrutide arrives, it'll be there for you.

Last edited: Jun 26, 2024 at 12:49 PM
30 0hyun_seoul, jim_asheville, matt_MKE and 27 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Jun 26, 2024 at 1:32 PM#9

That's actually a really helpful perspective. You're right that tirzepatide is already amazing compared to what was available even 5 years ago. I'll keep doing what I'm doing and look forward to the next generation when it arrives.

Thanks everyone for the detailed responses. This community is great for cutting through the hype and giving realistic expectations. 🙌

29 24TirzTom, TrialTracker_MD, JennaRN and 26 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register